ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
191 hedge funds and large institutions have $2.1B invested in Intercept Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 61 increasing their positions, 55 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $2.42B → $2.1B (-$328M)
29% less call options, than puts
Call options by funds: $159M | Put options by funds: $225M
Holders
191
Holding in Top 10
4
Calls
$159M
Puts
$225M
Top Buyers
| 1 | +$60.5M | |
| 2 | +$28.8M | |
| 3 | +$28.6M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$24.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$20.4M |
Top Sellers
| 1 | -$30.2M | |
| 2 | -$20.5M | |
| 3 | -$19.1M | |
| 4 |
MAM
Melqart Asset Management
London,
United Kingdom
|
-$16.9M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.4M |